Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD)Ugo Giovanni Falagario, Giuseppe Carrieri, Hannu J. Aronen et al.|European Urology Oncology|2020Cited by 105
Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk ScoreMax Peters, Hashim U. Ahmed, David Eldred‐Evans et al.|European Urology|2022Cited by 38
The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk CalculatorSneha Parekh, Ash Tewari, Parita Ratnani et al.|European Urology Open Science|2022Cited by 26